Amphastar Pharmaceuticals-Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) reported $170.53 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.8%. EPS of$ 0.74 for the same period compares to $1.04 a year ago.The reported revenue represents a surprise of -0.69% over the Zacks Consensus Estimate of$ 171.71 million. With the consensus EPS estimate being $0.66, the EPS surprise was +12.12%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compar ...